FINTEPLA® (Fenfluramine) Approved for Dravet Syndrome: Long-Term Study Confirms Safety and Efficacy
Feature
Text
Abbvie announces EU launch of PRODUODOPA® , a 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson's disease
AbbVie has announced the introduction of PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union.
Source: Abbvie Press Release
Text
